The utility of creatine kinase in status dystonicus and pre-status dystonicus
serum CK levels represent a potentially useful biomarker for dystonia severity that differs between pre-SD and SD, and provide a measure to track dystonia severity at an individual patient basis.
Authors
- Daniel Edward Lumsden (ORCID: https://orcid.org/0000-0002-5524-6177)
- Apostolos Papandreou (ORCID: https://orcid.org/0000-0001-5093-6075)
- Jean‐Pierre Lin (ORCID: https://orcid.org/0000-0001-9314-2259)
- Nicholas M. Allen (ORCID: https://orcid.org/0000-0002-8678-7507)
Institutions
- St Thomas' Hospital (GB)
- Ollscoil na Gaillimhe – University of Galway (IE)
- Evelina London Children's Healthcare (GB)
Publication Details
- Journal
- European Journal of Paediatric Neurology
- Published
- 2025-05-27
- DOI
- https://doi.org/10.1016/j.ejpn.2025.05.013
- Citations
- 2
- Primary Topic
- Genetic Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.82
Funders
- King's College London